Clinical Trials Browser

Phase 1/2 × Unknown × Sirolimus × Clear all

NCT05625919 2022-11-28

A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

Phase 1/2 Unknown

Perivascular Epithelioid Cell Neoplasms

NCT03805399 2022-08-10

FUTURE

Phase 1/2 Unknown

Triple Negative Breast Neoplasms

NCT03662412 2018-09-07

Study of Sirolimus in Patients With Advanced Pancreatic Cancer

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms